Astrid Schott

A Phase I and Pharmacokinetic Study of the Oral Histone Deacetylase Inhibitor, MS-275, in Patients with Refractory Solid Tumors and Lymphomas

Lia Gore, Mace L. Rothenberg, Cindy L. O’Bryant et al. · Clinical Cancer Research · 2008 · 167 citations · Full text

Isolated Tumor Cells Are Frequently Detectable in the Peritoneal Cavity of Gastric and Colorectal Cancer Patients and Serve as a New Prognostic Marker

Astrid Schott, Ilka Vogel, Uwe Krueger et al. · Annals of Surgery · 1998 · 162 citations

Multicenter phase II trial of the histone deacetylase inhibitor pyridylmethyl-N-{4-[(2-aminophenyl)-carbamoyl]-benzyl}-carbamate in pretreated metastatic melanoma

Axel Hauschild, Uwe Trefzer, Claus Garbe et al. · Melanoma Research · 2008 · 80 citations

Tumor Biology, Oncology, Histone Deacetylase Inhibitor +14

Phase III Intergroup Study of Fludarabine Phosphate Compared With Cyclophosphamide, Vincristine, and Prednisone Chemotherapy in Newly Diagnosed Patients With Stage III and IV Low-Grade Malignant Non-Hodgkin's Lymphoma

Anton Hagenbeek, Houchingue Eghbali, S. Monfardini et al. · Journal of Clinical Oncology · 2006 · 77 citations · Full text

[Immunocytologic detection of disseminated tumor cells in the peritoneal cavity and bone marrow in patients with pancreatic carcinoma].

Hartmut Juhl, Holger Kalthoff, Uwe Krüger et al. · PubMed · 1994 · 20 citations